{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:40:11Z","timestamp":1792716011679,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1016\/j.biomaterials.2005.01.063","type":"journal-article","created":{"date-parts":[[2005,3,12]],"date-time":"2005-03-12T11:55:56Z","timestamp":1110628556000},"page":"5386-5394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Local perivascular delivery of anti-restenotic agents from a drug-eluting poly(<mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" altimg=\"si1.gif\" overflow=\"scroll\"><mml:mrow><mml:mi>\u03b5<\/mml:mi><\/mml:mrow><\/mml:math>-caprolactone) stent cuff"],"prefix":"10.1016","volume":"26","author":[{"given":"Nuno M.M.","family":"Pires","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barend L.","family":"van der Hoeven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margreet R.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis M.","family":"Havekes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart J.","family":"van Vlijmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim E.","family":"Hennink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul H.A.","family":"Quax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Wouter","family":"Jukema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2005.01.063_bib1","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJM199404073301407","article-title":"Percutaneous transluminal coronary angioplasty","volume":"330","author":"Landau","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biomaterials.2005.01.063_bib2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0735-1097(01)01742-9","article-title":"Coronary in-stent restenosis: current status and future strategies","volume":"39","author":"Lowe","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.biomaterials.2005.01.063_bib3","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1161\/01.CIR.94.6.1247","article-title":"Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study","volume":"94","author":"Hoffmann","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.biomaterials.2005.01.063_bib4","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJMoa012843","volume":"346","author":"Morice","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biomaterials.2005.01.063_bib5","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1161\/01.CIR.0000047700.58683.A1","article-title":"TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions","volume":"107","author":"Grube","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.biomaterials.2005.01.063_bib6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijcard.2004.01.021","article-title":"Drug-eluting stents: results, promises and problems","volume":"99","author":"van der Hoeven","year":"2005","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.biomaterials.2005.01.063_bib7","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1161\/01.CIR.103.4.562","article-title":"Adenoviral expression of a urokinase receptor-targeted protease inhibitor inhibits neointima formation in murine and human blood vessels","volume":"103","author":"Quax","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.biomaterials.2005.01.063_bib8","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1172\/JCI1293","article-title":"Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular response to injury in mice","volume":"101","author":"Moroi","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.biomaterials.2005.01.063_bib9","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1161\/01.RES.87.3.248","article-title":"Accelerated atherosclerosis by placement of a perivascular cuff and a cholesterol-rich diet in ApoE*3-Leiden transgenic mice","volume":"87","author":"Lardenoye","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.biomaterials.2005.01.063_bib10","series-title":"Biodegradable polymers as drug delivery systems","first-page":"71","article-title":"Poly-\u03b5-caprolactone and its copolymers","author":"Pitt","year":"1990"},{"key":"10.1016\/j.biomaterials.2005.01.063_bib11","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/jps.2600681219","article-title":"Sustained drug delivery systems II: factors affecting release rated from poly(\u03b5-caprolactone) and related biodegradable polyesters","volume":"68","author":"Pitt","year":"1979","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.biomaterials.2005.01.063_bib12","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/0142-9612(91)90037-B","article-title":"Physico-mechanical properties of degradable polymers used in medical applications: a comparative study","volume":"12","author":"Engelberg","year":"1991","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2005.01.063_bib13","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v15.i4.20","article-title":"Bioerodible polymers for ocular drug delivery","volume":"15","author":"Deshpande","year":"1998","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"10.1016\/j.biomaterials.2005.01.063_bib14","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/0142-9612(95)93577-Z","article-title":"Monocryl suture, a new ultra-pliable absorbable monofilament suture","volume":"16","author":"Bezwada","year":"1995","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2005.01.063_bib15","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/S0002-9378(89)80015-8","article-title":"Clinical evaluation of the Capronor contraceptive implant: preliminary report","volume":"160","author":"Darney","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.biomaterials.2005.01.063_bib16","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0142-9612(81)90060-0","article-title":"Aliphatic polyesters II. The degradation of poly(dl-lactide), poly(\u03b5-caprolactone), and their copolymers in vivo","volume":"2","author":"Pitt","year":"1981","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2005.01.063_bib17","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/jbm.820190408","article-title":"The intracellular degradation of poly(\u03b5-caprolactone)","volume":"19","author":"Woodward","year":"1985","journal-title":"J Biomed Mater Res"},{"key":"10.1016\/j.biomaterials.2005.01.063_bib18","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1016\/S0735-1097(00)01020-2","article-title":"Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over six months","volume":"36","author":"Drachman","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.biomaterials.2005.01.063_bib19","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00019501-200409000-00003","article-title":"Drug-eluting stents: caution and concerns for long-term outcome","volume":"15","author":"Virmani","year":"2004","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.biomaterials.2005.01.063_bib20","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1023\/A:1016032207246","article-title":"Development of a polymeric surgical paste formulation for taxol","volume":"13","author":"Winternitz","year":"1996","journal-title":"Pharm Res"},{"key":"10.1016\/j.biomaterials.2005.01.063_bib21","first-page":"4146","article-title":"The suppression of human prostate tumor growth in mice by the intratumoral injection of a slow-release polymeric paste formulation of paclitaxel","volume":"60","author":"Jackson","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.biomaterials.2005.01.063_bib22","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijpharm.2003.10.010","article-title":"The characterization novel polymeric paste formulations for intratumoral delivery","volume":"270","author":"Jackson","year":"2004","journal-title":"Int J Pharm"},{"key":"10.1016\/j.biomaterials.2005.01.063_bib23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S1051-0443(07)61408-0","article-title":"Complete inhibition of intimal hyperplasia by perivascular delivery of paclitaxel in balloon-injured rat carotid arteries","volume":"12","author":"Signore","year":"2001","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.biomaterials.2005.01.063_bib24","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s100169900177","article-title":"Locally applied antisense oligonucleotide to proliferating cell nuclear antigen inhibits intimal thickening in experimental vein grafts","volume":"12","author":"Fulton","year":"1998","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.biomaterials.2005.01.063_bib25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0021-9150(98)00147-6","article-title":"Effects of a single local administration of cilostazol on neointimal formation in balloon-injured rat carotid artery","volume":"142","author":"Ishizaka","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.biomaterials.2005.01.063_bib26","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.athoracsur.2003.10.008","article-title":"Local application of rapamycin inhibits neointimal hyperplasia in experimental vein grafts","volume":"77","author":"Schachner","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.biomaterials.2005.01.063_bib27","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1161\/01.CIR.100.8.861","article-title":"Inhibition of neointima hyperplasia of mouse vein graft by locally applied suramin","volume":"100","author":"Hu","year":"1999","journal-title":"Circulation"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961205001134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961205001134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T14:46:20Z","timestamp":1758897980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961205001134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":27,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S0142961205001134"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2005.01.063","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Local perivascular delivery of anti-restenotic agents from a drug-eluting poly(-caprolactone) stent cuff","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2005.01.063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}